Brian Vala Nahed

Brian Nahed M.D. is a neurosurgeon at the Massachusetts General Hospital at Harvard Medical School. Dr. Nahed specializes in brain tumors and spinal disorders. As an attending neurosurgeon and assistant professor, he has appointments with the MGH Cancer Center, Stephen E. and Catherine Pappas Center for Neurooncology and is a faculty member of the Harvard Medical School.
Education and Medical Training
In college, Dr. Nahed majored in Neuroscience at the University of California, Los Angeles and was awarded Phi Beta Kappa, his department's highest graduating honor and named one of the Bruins of the Year. He attended the Yale School of Medicine where he was awarded the Doris Duke Clinical Fellowship. He completed his internship in surgery and his residency in neurological surgery at the Massachusetts General Hospital. He completed a fellowship in complex spine at the New England Baptist Hospital under the mentorship of Dr. Eric Woodard.
Clinical career
Dr. Nahed specializes in the care of patients with brain tumors, specifically glioma, glioblastoma, meningioma, metastatsis. As a physician-scientist, he is actively leading a translational research project for patients with brain tumors.
Research career
As a researcher, Dr. Nahed began his career working under the mentorship of Drs. David Hovda and Stefan Lee studying the effects of an enriched environment on traumatic brain injury. During medical school, Dr. Nahed was mentored by Dr. Murat Gunel studying the genetics of intracranial aneurysms at the Yale School of Medicine in collaboration with Dr. Richard Lifton. During residency, Dr. Nahed completed a post-doctorate fellowship under the mentorship of Drs. Daniel Haber, and Shyamala Maheswaran at the Massachusetts General Hospital Cancer Center. Dr. Nahed's research focuses on identifying and analyzing circulating tumor cells in the blood of patients with brain cancer. Through a collaboration between bioengineers, molecular biologists and clinicians, a circulating tumor cell capture device was developed to capture and detect tumor cells from patients with cancer. Under the mentorship of Drs. Daniel Haber, Shyamala Maheswaran, and Mehmet Toner, they aim to harness this technology to genetically characterize tumor cells without needing an invasive biopsy, and determine responsiveness to targeted cancer drugs. It also offers the opportunity to study cancer cells define their molecular vulnerabilities and help design new therapies to prevent cancer metastasis.
National Committees
Dr. Nahed is an active member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, and Council of State Neurological Surgeons and serves on several national committees. He is a graduate of the Clinical Effectiveness at the Harvard School of Public Health and is actively engaged in research studying the socioeconomic aspects and outcomes in neurosurgery.
Publications
http://www.ncbi.nlm.nih.gov/pubmed/?term=nahed+b

Main Menu

See Also

Main Menu